Actuate Therapeutics (ACTU) EPS (Diluted) (2023 - 2025)
Actuate Therapeutics (ACTU) EPS (Diluted) (2023 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 0.15 |
| 10 | Actuate Therapeutics | 28.65 Mn | 28.65 Mn | - | -0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.22 |
| Sep 30, 2025 | -0.25 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.32 |
| Dec 31, 2024 | -0.76 |
| Sep 30, 2024 | -0.49 |
| Jun 30, 2024 | -3.47 |
| Mar 31, 2024 | -5.06 |
| Dec 31, 2023 | -5.27 |
| Sep 30, 2023 | -4.32 |
| Jun 30, 2023 | -3.93 |